The Careside System is easy to use and can be operated by non-technical personnel with appropriate training. It also employs the same industry standard technology as large testing devices deployed in hospitals and commercial laboratories. This is accomplished either during the patient testing process or during a simple ten-minute testing cycle with reusable quality control cartridges. CLIA governs quality assurance and quality control processes and test result reporting for healthcare providers. This special clearance enables properly trained non-lab personnel to operate the device in any licensed laboratory.
Reagents are the chemicals within the test cartridges that react with a patient's blood.
Inc. This acquisition included intellectual property as well as equipment and other assets to continue the development of the diagnostic technology and create a commercial product. Several senior members of Careside's management team worked on this project at SmithKline. Careside, Inc. launched the Careside System in the fourth quarter 1999 with a 53-test menu. This menu also addresses over 50 percent of the test volume ordered in hospitals. Careside, Inc. is dedicated to making the Careside System, and decentralized testing, the standard for routine and critical care blood testing in hospitals, physician offices, nursing homes and everywhere in vitro diagnostics is performed.